Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US House Appropriators Have Little Left To Say About Allowing Cannabinoids In Supplements

Jul 01 2021

• By Malcolm Spicer

• Source: Alamy

Related Content

CBD Market Provides ‘Enormous Incentive’ For FDA's Regulatory Answer But Decision Remains TBD

Dec 10 2020

US House Appropriators Request CBD Enforcement As They Ante Up $5M For FDA's Rule Development

Jul 10 2020

Potential For US Requiring Supplement Registration Underscored During FDA’s Hiatus From Inspections

Jul 17 2020

FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements

Apr 17 2019

Biden Administration Pause On Pending Trump-Era Rules Stalls FDA Cannabinoids Guidance Progress

Jan 27 2021

House Appropriators Go Low On FDA's Budget

Jun 25 2021

Mixing Food In Legislation Changing US FDA Cannabinoid Rules Could Choke Its Progress

May 25 2021

Requiring Infant Formula, Medical Food Shortage Updates Included In US FDA Budget Request

May 30 2021

Additional Topics

International United States US States Cannabidiol CBD Dietary Supplements FDA Legislation Enforcement Advertising, Marketing & Sales Commercial Ingredients Manufacturing Policy Politics Regulation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window